Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
C2HEST score – Heart Failure risk score: predictive value for one-year mortality and re-admission after discharge
Session:
Posters (Sessão 2 - Écran 4) - Insuficiência Cardíaca 2 - Índices e Factores de Prognóstico
Speaker:
Joana Laranjeira Correia
Congress:
CPC 2022
Topic:
D. Heart Failure
Theme:
11. Acute Heart Failure
Subtheme:
11.2 Acute Heart Failure – Epidemiology, Prognosis, Outcome
Session Type:
Pósters Electrónicos
FP Number:
---
Authors:
Joana Laranjeira Correia; Inês Pires; João Miguel Santos; Vanda Devesa Neto; Gonçalo Ferreira; José Costa Cabral; António Costa
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-size:12.0pt">Background:</span></strong> The C<sub>2</sub>HEST score has been validated for predicting atrial fibrillation in the general population or post-stroke patients. The C<sub>2</sub>HEST score is calculated with the following parameters: coronary artery disease or chronic obstructive pulmonary disease [1 point each]; hypertension [1 point]; elderly [age ≥75 years, 2 points]; systolic heart failure [2 points]; thyroid disease [hyperthyroidism, 1 point]). The authors aimed to analyse the predictive value of this score for mortality and readmission 12 months after discharge in hospital admissions due to acute heart failure (HF)</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Methods</strong>: A retrospective study of patients admitted due to acute HF in the cardiology department of a tertiary centre was performed. The C<sub>2</sub>HEST score was determined for all patients. Follow-up started after discharge and ended upon 12 months after study entry, hospital re-hospitalization or death. All subjects were divided into two groups: higher (=>5 points) and lower (<4 points) score. Kaplan-Meier survival curves were obtained to compare 12-month mortality and 12-month hospital re-hospitalization between both groups. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Results</strong>: 780 patients were included in the study. 50.5% were female and the mean age was 77±10 years old. The mean Ejection Fraction (EF) was 49.3±16.5% and the mean C<sub>2</sub>HEST score was 3.14±1.44. The following Kaplan-Meier survival curves were determined for 12 months mortality - X2 6,480 (p=.011) and 12 months re-hospitalization - X2 0.154 (p=.695).</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif">The C<sub>2</sub>HEST score demonstrated to be an independent variable in predicting the one-year mortality <span style="background-color:white"><span style="color:black">after discharge</span></span> (HR: 1.297, p = .003) after adjusting for other prognostic variables such as age, gender, diabetes mellitus, atrial fibrillation, and hypertension</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong>Conclusion:</strong> In this population, the C<sub>2</sub>HEST score proved to be a useful multivariable score model for the one-year mortality <span style="background-color:white"><span style="color:black">after discharge</span></span>. Thus, C<sub>2</sub>HEST score can be a tool in daily practice to identify patients who benefit from an earlier reevaluation and therapeutic optimization. However, these results were not achieved for the one-year re-hospitalization. </span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site